Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Tularik |
---|---|
Information provided by: | Tularik |
ClinicalTrials.gov Identifier: | NCT00043433 |
The purpose of the study is to determine whether T900607-sodium is effective and safe in treating hepatocellular carcinoma, a type of liver cancer.
Condition | Intervention | Phase |
---|---|---|
Hepatocellular Carcinoma |
Drug: intravenous T900607-sodium |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria
Exclusion Criteria
United States, California | |
Scripps Health Center | |
La Jolla, California, United States, 92037 | |
University of California San Diego | |
La Jolla, California, United States, 92093 | |
United States, District of Columbia | |
George Washington University | |
Washington, District of Columbia, United States, 20037 | |
United States, Florida | |
H. Lee Moffitt Cancer Center | |
Tampa, Florida, United States, 33612 | |
United States, Missouri | |
Ellis Fischel Cancer Center | |
Columbia, Missouri, United States, 65203 | |
United States, New Mexico | |
University of New Mexico | |
Albuquerque, New Mexico, United States, 87131 | |
United States, New York | |
University of Rochester | |
Rochester, New York, United States, 14642 | |
United States, Ohio | |
Ireland Cancer Center | |
Cleveland, Ohio, United States, 44106 | |
United States, Pennsylvania | |
University of Pennsylvania | |
Philadelphia, Pennsylvania, United States, 19104 | |
Fox Chase Cancer Center | |
Philadelphia, Pennsylvania, United States, 19111 | |
United States, Texas | |
University of Texas Southwestern Medical Center | |
Dallas, Texas, United States, 75390 | |
China | |
Queen Mary Hospital | |
Hong Kong, China |
Study Chair: | Charlene Sum | Tularik |
Study ID Numbers: | T-607-004 |
Study First Received: | August 8, 2002 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00043433 |
Health Authority: | United States: Food and Drug Administration |
HCC |
Liver Neoplasms Liver Diseases Digestive System Diseases Digestive System Neoplasms Carcinoma, Hepatocellular Liver neoplasms |
Gastrointestinal Neoplasms Adenocarcinoma Hepatocellular carcinoma Neoplasms, Glandular and Epithelial Carcinoma |
Neoplasms Neoplasms by Site Neoplasms by Histologic Type |